More recently, genome-wide screens for somatic mutations18 and analysis of frequently mutated residues in tumor samples19 have led to the identification of mutations in PIK3CB in tumor cells from a diverse range of cell lineages. This evidence concerns the gene PIK3CB and neoplasm.